Effect of Longmu Gegen Decoction on herpes zoster and its effect on T cell subsets
- Conditions
- herpes zoster
- Registration Number
- ITMCTR2100005123
- Lead Sponsor
- Xiyuan Hospital of CACMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Meets the typical diagnostic criteria for herpes zoster; 1-3 days from onset to treatment; Pain VAS score less than 6 points; Between the ages of 18 and 80; Untreated; No cognitive impairment; Volunteer to be tested and sign an informed consent form.
Herpes zoster special type, such as meningeal herpes zoster, visceral herpes zoster, herpes zoster without rash, generalized herpes zoster; Allergic to Chinese medicine or unwilling to Chinese medicine treatment; Patients with severe heart, lung and other systemic diseases and malignant tumors; Patients with systemic lupus erythematosus and other immune diseases and the application of immunosuppressive agents; Pregnant or lactating women and those with a history of mental illness; Severe adverse reactions occurred during the period of taking the drug and known allergies to the drug; Join other clinical investigators.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T cell subsets (CD3+, CD3+CD4+, CD3+CD8+);
- Secondary Outcome Measures
Name Time Method